INFORMATION BY CANCER TYPE
Expert discusses three promising options to treat patients with medullary thyroid cancer.
Patients who choose not to have their thyroid cancer treated often have feelings of anxiety and isolation, and are at a risk of disengaging from the health care system because they might not feel supported.
A recent study found that some late effects are more prevalent in patients who were diagnosed with thyroid cancer before 40 compared to those who were diagnosed at a later age.
Clinical trial enrollment must become speedier for patients with rare diseases such as anaplastic thyroid cancer, says Maria Cabanillas, M.D.
Encapsulated follicular variant of papillary thyroid cancer may actually not be cancer at all, according to Yuri E. Nikiforov.
Marcia S. Brose discusses Lenvima for patients with progressive radioactive iodine (RAI)-refractory differentiated thyroid cancer.
Danielle Nicosia, a survivor of thyroid cancer, discusses being misdiagnosed.
Nexavar and Lenvima have significantly altered the treatment paradigm for patients with advanced RAI-refractory differentiated thyroid cancer, with combination strategies hoping to further build upon this success.
Bethany Andrews Rhoten, Assistant Professor of Nursing, Vanderbilt University, discusses how patients with cancer can cope with body image issues.
Search Cancer Drugs & Terms
Information about treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy
Parathyroid Cancer Treatment (PDQ®)
[ Patients ]
Expert-reviewed information summary about the treatment of parathyroid cancer.
Thyroid Cancer Treatment (PDQ®)
[ Patients ]
Expert-reviewed information summary about the treatment of thyroid cancer.